Author Correction: Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
Guardado en:
Autores principales: | Xueju Zhang, Weiwei Liu, Jie Zan, Chuanbin Wu, Wen Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c47bd988c034cefb0f5a4c5418d59dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
por: Nikisha Carty, et al.
Publicado: (2013) -
Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice.
por: Neel R Nabar, et al.
Publicado: (2012) -
Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
por: Xiaomei Lu, et al.
Publicado: (2019) -
The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
por: Dmitrii Smirnov, et al.
Publicado: (2021) -
Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
por: Long-Long Cao, et al.
Publicado: (2021)